The factors and processes involved in regression of the primate corpus luteum (CL) are complex and not fully understood.
Introduction
The corpus luteum (CL) is a transient endocrine gland whose structure and function are regulated by luteotrophic (stimulates luteal function) and luteolytic (inhibits luteal function) stimuli. As the CL is the primary source of progesterone during menstrual cycles and early pregnancy, and progesterone is required for maintenance of pregnancy in all mammalian species, understanding the regulation of luteal structure and function has important implications for reducing early embryonic losses and improving assisted reproduction technologies. The follicle, which primarily secretes estrogen, is converted to the progesterone-producing CL following ovulation in a process known as luteinization. LH is known to control formation of the CL and production of progesterone by luteal cells. In the absence of fertilization, luteal production of progesterone ceases and the CL regresses in a process known as luteolysis, which is necessary to allow subsequent ovulation and chance at pregnancy in the next ovarian (menstrual) cycle.
The primate CL is absolutely dependant on LH for luteinization and maintenance of progesterone secretion. Ablation of LH production via administration of GnRH antagonists to both monkeys and women with developing (Fraser et al., 1987; Dubourdieu et al., 1991) or fully developed (Mais et al., 1986; Duffy et al., 1999) CL reduces progesterone secretion and results in premature luteolysis. Furthermore, replacement of LH, but not FSH, restores luteal function in GnRH antagonisttreated monkeys (Collins et al., 1986) .
In contrast to non-primate species, luteolytic factors responsible for regression of the primate CL at the end of the luteal phase in nonfertile cycles are not known. As reviewed by others (Niswender et al., 2000; Stouffer, 2006) , it is well established that prostaglandin F2a (PGF2a) of uterine origin initiates luteolysis in non-primate species. However, removal of the uterus does not extend the normal lifespan of the CL in non-human primates or women, indicating that the signal initiating luteolysis is not of uterine origin and may be an intraovarian mechanism in primates (Auletta et al., 1973; Ranney and Abu-Ghazaleh, 1977; Castracane et al., 1979) . PGF2a may still have a luteolytic role as intraluteal infusion of PGF2a analogs causes luteolysis in monkeys and women (Auletta et al., 1973; Wentz and Jones, 1973) . However, intraluteal administration of a prostaglandin synthesis inhibitor in macaques shortened CL lifespan rather than extending it as was predicted (Sargent et al., 1988) . Thus, the origin and potential role of PGF2a in spontaneous luteolysis of the primate CL remain unresolved. It is known that luteolysis of the primate CL is associated with a reduced sensitivity to LH as the CL ages, which occurs without changes in the number of LH/chorionic gonadotrophin receptors expressed by luteal cells (Cameron and Stouffer, 1982; Eyster et al., 1985; Brannian and Stouffer, 1991) . Pulses of LH must increase or another LH-receptor ligand (i.e. CG) must be present to maintain the primate CL by the end of the normal luteal phase (Duffy et al., 1999) . While the mechanism(s) resulting in the reduction in LH sensitivity at the end of the luteal phase are currently unclear, the exponential rise in levels of CG at pregnancy initiation (implantation) are able to rescue the CL presumably by overcoming this decreased sensitivity to pulsatile levels of LH (Zeleznik, 1998) .
Given that: (i) the factors controlling luteolysis in primates are not known, and (ii) luteolysis in primates is likely controlled by an intraovarian mechanism, interrogating global gene expression patterns in CL undergoing either spontaneous or induced luteolysis may allow for the identification of novel factors controlling regression of the primate CL. With the release of the Affymetrix TM Rhesus Macaque Total Genome DNA Microarray in 2005, researchers can now monitor changes in gene expression across the entire macaque transcriptome. Therefore, studies were performed to identify global changes in the luteal transcriptome during natural luteolysis (Bogan et al., 2008a (Bogan et al., , b, 2009 . Additionally, as LH withdrawal is known to cause premature luteal regression, studies have monitored changes in gene expression associated with gonadotrophin (Bishop et al., 2009; Priyanka et al., 2009) ablation and replacement. While the role of PGF2a in spontaneous luteolysis of the primate CL is unclear, exogenous PGF2a administration is capable of inducing premature luteal regression when given toward the end of the luteal phase (Auletta et al., 1973; Wentz and Jones, 1973; Summers et al., 1985) . Such an increase in the sensitivity to the luteolytic effects of PGF2a parallels a significant induction of prostaglandin F2a receptor levels (.30-fold) during spontaneous luteal regression in the rhesus macaque (Bogan et al., 2008a, b) . Administration of the PGF2a analog has also been used to identify differentially expressed mRNAs that may serve as potential luteolytic factors in bonnet monkeys (Priyanka et al., 2009) . By comparing gene expression data across these various publically accessible microarray expression databases, we may begin to uncover the mechanisms responsible for regression of the primate CL during non-fertile cycles.
Analysis of microarray data from the macaque CL of the natural menstrual cycle (Priyanka et al., 2009; Bishop et al., 2009; Bogan et al., 2009 ) utilized the Affymetrix TM Rhesus GeneChip w expression array, but Priyanka et al. (2009) hybridized bonnet monkey RNA to this chip. While the bonnet monkey is a macaque species, only 108 records for bonnet monkey nucleotide sequences exist in the NCBI database. BLAST alignment comparing some of these bonnet RNA sequences to known rhesus sequences reveals 97 -99% identity between genes of these macaque species. This modest dissimilarity could lead to a percentage of probesets on the rhesus gene chip that results in either no, incomplete, or incorrect hybridization (Lu et al., 2009) . There are currently no standard methods to normalize probe measurements that allow direct comparisons between related, but different species hybridized to the same arrays. While direct comparisons between rhesus and bonnet monkeys could give misleading results, particularly false negatives due to minor sequence differences as discussed above, comparative analysis of the array sets can be performed by noting similar changes in gene expression and affected gene pathways between the individually analyzed experiments using Gene Set Enrichment Analysis or GSEA (Lu et al., 2009) . A GSEA is performed by subjecting all experiments separately to the same analytical conditions [i.e. same normalization, statistical tests, threshold for expression changes and false-discovery rate (FDR) corrections] to generate a data set for each experiment. Then, one can interrogate the differentially expressed genes from different experimental data sets for similarities in changes in gene pathways and gene expression between species.
The primate luteal phase can be divided into several functional stages: early (formation of the CL), mid (fully functional), mid-late (time period of implantation in fertile cycles), late (onset of functional regression) and very late (onset of structural regression) (Bogan et al., 2008a, b) . In the rhesus macaque, previous microarray analysis by Bogan et al. (2008a, b) demonstrated that dynamic gene changes take place between each of these stages of the luteal phase. When performing pairwise analyses between luteal phase stages in a chronological manner, 380 probe sets from early to mid, 93 from mid to mid-late, 171 from mid-late to late and 2320 from late to very-late stages changed ≥2-fold (P , 0.05, Benjamini and Hochburg FDR correction). Thus, the majority of changes in gene expression during the CL's lifespan are associated with luteolysis (Bogan et al., 2008a, b) . At least four major groups of related genes were differentially expressed during the luteal phase, including those involved in: (i) steroidogenesis; (ii) prostaglandin biosynthesis, metabolism and signaling; (iii) hormone and growth factor signaling and (iv) immune system function. These gene groups may play integral roles in luteolysis of the primate CL, and their potential involvement in luteal regression can be further explored by interrogating their expression in induced luteolytic models.
Comparison of GnRH/LH withdrawal and spontaneous luteal regression
It is well documented that short-term treatment with GnRH antagonists induces luteal regression in primate species (Yadav et al., 2004; Xu et al., 2005) . It is of interest to compare gene changes during GnRH antagonist-induced and natural regression to identify common themes and verify signaling pathways that are activated during luteal regression. Such comparisons may also identify novel GnRH/ LH-sensitive signaling pathways in the CL that are not activated during natural regression. These could represent alternate survival pathways that are only active in the LH-sensitive CL during the early to mid-luteal phase. Therefore, arrays of Bogan et al. 
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w Command Console w ). For more detailed protocol information for these experiments see GEO entry in GEO DataSets (enter GSE # at http://www.ncbi.nlm.nih.gov/gds). The datafiles from each experiment were loaded into the web-based software GeneSifter (Geospiza, Inc.) and analyzed separately. The Robust Multichip/Multiarray Analysis (RMA) algorithm was used to normalize hybridization data on a chip-by-chip basis (Noriega et al., 2009) . The RMA algorithm performs a probe-level quantile normalization for each array, and then normalizes all arrays in a given analysis (for more detail see Bolstad et al., 2003) . Pairwise comparisons were then performed between functional and regressed CL, as well as between functional controls and induced luteolysis for CET and Antide experiments. Transcripts changing expression significantly (P ≤ 0.05, Benjamini and Hochburg FDR correction) ≥2-fold from each experiment were analyzed for overlapping genes in pathways that are coordinately regulated during spontaneous luteal regression (Bogan, et al., 2009; Bogan and Hennebold, 2010) : cholesterol pathways (including those relevant to cholesterol homeostasis, biosynthesis, catabolism/metabolism, efflux, import, storage and transport); immune system processes; prostaglandin biosynthetic and metabolic pathways; as well as steroid biosynthetic, metabolic and catabolic pathways. Results are listed in Table I , and genes are highlighted in bold when present in more than one experiment.
When the experiments are analyzed separately, CET-induced luteal regression resulted in 239 transcripts significantly changing in expression, and Antide-induced luteolysis altered 1604 transcripts, whereas 378 transcripts changed during spontaneous luteal regression (see Supplementary data, file S1 for list of all transcripts identified as exported from GeneSifter). The differences in total number of transcript changes between experimental models could reflect differential sensitivity of the Affymetrix TM chip to rhesus and bonnet monkey cDNA. However, it is more likely that this reflects differences in timing or duration of treatment during the luteal phase. Note that all experiments were performed during different luteal days. The spontaneously regressing rhesus macaque CL were collected on luteal days 14-16; CL of luteal days 14 -16 with progesterone levels .1.5 ng/ml serving as non-regressed controls [functional CL (Bogan et al., 2009) ], those from animals collected with levels of progesterone levels below 0.5 ng/ml were considered functionally regressed CL. All CET-treated animals had one injection of GnRH antagonist on luteal day 7 and CL were collected 24 h post-treatment on Day 8 (Priyanka et al., 2009) ; untreated timematched CL collected as control samples (luteal day 8). The CL from Antide-treated animals were given three injections of GnRH antagonist over 3 days on luteal days 9-11 and collected on luteal day 12, i.e. 72 h after treatment began (Bishop et al., 2009) ; time-matched untreated CL were collected on luteal day 12, which served as control samples. Regardless of differences in timing and duration of treatment, as evidenced by Table I there are many commonly affected genes in both spontaneous and induced models of luteal regression.
An attempt was made to compare experiments in which GnRH antagonist-induced regression was prevented by replacement of LH: Bishop et al. (2009) rhesus control luteal day 12 and Antide + LH samples, and Priyanka et al. (2009) bonnet vehicle control samples luteal day 8 experiment one and CET + LH samples luteal day 8 experiment two. However, since rhesus CL were exposed to both Antide and LH on the same days, whereas CET-treated bonnet monkey CL were administered LH 24 h after onset of CET treatment, these experimental conditions are disparate. When pairwise analysis was performed to identify transcripts changing expression ≥2-fold (P ≤ 0.05, Benjamini and Hochburg FDR correction), the vehicle control luteal day 8 and CET + LH luteal day 8 (bonnet monkey) groups contained 14 308 transcripts with a significant difference in expression. In contrast, pairwise analysis of control luteal day 12 and Antide + LH (rhesus monkey) identified statistically significant differences in expression .2-fold of only 40 transcripts without using the FDR; with the FDR correction no significant differences are found. Thus LH replacement beginning at the onset of GnRH antagonist treatment results in a transcriptome virtually indistinguishable from a CL during the natural menstrual cycle. LH treatment begun 24 h after onset of antagonist treatment appears to act as a rescue signal after CL regression has already begun, but many luteal activities are not restored to pretreatment levels.
Prostaglandin-induced luteal regression
In many non-primate species there is a direct link between prostaglandins of uterine origin and luteal regression (Stouffer, 2006) . In primate species, prostaglandins of ovarian origin, rather than of uterine origin, may also promote luteolysis (Bogan et al., 2008a, b) . Therefore, pairwise analysis was performed on control and PGF2a-treated CL of Priyanka et al. (CEL files representing luteal days 10 -11; GSE7971 were RMA-transformed and significance set at changes in expression ≥2-fold P ≤ 0.05 after FDR correction) and affected pathways of interest in this data set were mined noting similarities between functional and GnRH-induced regression. These results are also presented in Table I . Prostaglandin-induced luteal regression resulted in changes in expression of 529 transcripts ≥2-fold (FDR, P , 0.05, see Supplementary data, file S1 for a list of all transcripts exported from GeneSifter). One should also note that the prostaglandin-treated CL were exposed to the PGF2a analog Iliren at 0900, 1700 and 0100 h on luteal day 10 and collected on day 11, i.e. 24 h after initiation of treatment (Priyanka et al., 2009) . Genes identified in Table I 
Genes highlighted in bold indicate expression changes in more than one experimental group. CL, corpus luteum; GnRH antagonists Antide and Cetrotide; PGF2, prostaglandin F2.
a Genes present in each experimental group (column) represent those that changed in expression significantly relative to corresponding controls.
Commonalities between spontaneous and induced luteal regression
Changes in mean expression levels of genes in the selected ontologies analyzed between spontaneous, GnRH antagonist-and PGF2a-induced luteolysis (Table I) are presented in Table II . When differences between RMA-transformed mean values of functional versus regressed CL are significant, this is indicated by grey. Levels are not included for non-significant gene changes. Note that no one gene shows similar levels of significant expression changes between control and all types of luteal regression (both spontaneous and induced). Although there were several genes where mean levels of expression appeared to be different, this difference did not approach statistical significance. Antide-treated and PGF2a-treated CL share many changes in gene expression as shown in Table II . Several changes in expression of selected genes during spontaneous luteal regression were similar to Antide-and/or PGF2a-induced regression. CET-treated CL had the fewest differentially expressed genes in common with spontaneous, Antide-induced, or PGF2a-induced luteal regression in these selected ontologies. An example of a cholesterol ontology gene affected similarly during spontaneous and both GnRH-antagonist-induced luteolysis is the low-density lipoprotein receptor (LDLR ; Table II , Fig. 1A ). Cytochrome P450, family 3, subfamily A, polypeptide 5 (CYP3A5), is a glucocorticoid-inducable member of the cytochrome P450 superfamily of enzymes found in the liver; in the ovary it may be involved in C-18, C-19 and C-21 steroid metabolism (NCBI GeneID: 1577). CYP3A5 was downregulated in both spontaneous and PGF2a-induced, but not GnRH-antagonist-induced luteolysis (Table II) . Aldose reductase (AKR1B10) is an example of a gene with similar changes in all data sets, but that did not approach significance for each: AKR1B10 is significantly down-regulated during spontaneous, Antide-induced and PGF2a-induced luteal regression, while CET-induced regression indicated a downward trend (Table II, Fig. 1B ).
Other genes outside the four major ontologies were also altered by spontaneous, GnRH antagonist-and PGF2a-induced luteolysis (see Supplementary data, file S1). Included in Table II are expression levels of three of these genes previously identified as sensitive to Antide-induced regression (Bishop et al., 2009) . The gene sterol-C4-methyl oxidase-like (SC4MOL; Table II, Fig. 1C ), participates in cholesterol biosynthesis (NCBI Gene ID: 6307). The representative transcript for SC4MOL is not fully annotated to cholesterol ontologies, and thus is not represented in Table I . SC4MOL is down-regulated during spontaneous and all forms of induced regression. Such genes could potentially be used as biomarkers for luteal regression and should be investigated further.
Two genes: major histocompatibility complex, Class II, DPa1 (human leukocyte antigen-DPA1) and src kinase associated phosphoprotein 2 (SKAP2) display changes in gene expression that differ between individual experiments in this analysis. For example, two different probesets displayed significant changes of SKAP2 expression between GnRH antagonist (CET and Antide) experiments. The probesets were designed differently: one is specific for the predicted rhesus SKAP2 mRNA sequence in NCBI's Nucleotide database (CET data set; NCBI accession # XM_001093819) and one was designed based on the longer identified human sequence (Antide data set; accession # NM_003930). Both of these transcripts have been validated in the rhesus monkey genome, (see rhesus genechip annotation resource University of Nebraska Non-Human Primate Genomics Center http://www.unmc.edu/rhesusgenechip/) and could represent splice variants, but these sequences are not yet updated in the NCBI database. Annotation issues are discussed further below, and are the reason why whenever possible the data from Table II was compiled from the same probeset and/or Unigene ID (UNIQID gene identifier) for each gene.
GnRH antagonist-induced luteal regression using Antide treatment identified more common genes in ontologies of interest with spontaneous luteal regression than treatment with CET (Tables I and II) . This could be due to species differences in transcript sequences producing false-negative hybridizations as discussed during explanation of GSEA. However, it may be more likely that this is due to differences in timing or duration of these experiments. Treatment with PGF2a and spontaneous luteal regression also affected genes in common listed in the ontologies of interest (Tables I and II) .
Impact of mining available microarray databases
Open access microarray databases play an important role in generating novel hypotheses for further study, as well as identifying possible biomarkers of tissue states. In other research areas, especially oncology, there are several related data sets listed in one of the most used public repositories: the NCBI GEO database (http://www.ncbi.nlm. nih.gov/geo/). As an example of how this public repository is used, mining of public data sets related to oncological processes resulted in papers reporting possible signaling networks in aggressive carcinomas, which may offer novel therapies (Yoshida et al., 2009) .
Our research group is developing a rhesus macaque ovarian microarray database spanning the ovulating follicle and CL formation, function and CG-rescue; NCBI GEO databases: gene expression data in pre-ovulatory follicle (Xu et al., 2008) , luteal phase (GSE10367), and luteal rescue (Bishop et al., 2010) in addition to those discussed in this review. The availability of additional expression databases evaluating changes in the ovarian/luteal transcriptome during different developmental stages, or after manipulation with luteotrophic or luteolytic stimuli, will help investigators identify novel factors regulating the structure and function of the CL. Results from database mining may also be useful in identifying cross-species similarities and differences in regulation of the CL. However, to date there is only one other CL database in the NCBI GEO repository from bovine CL (Goravanahally et al., 2009 ).
Limitations of microarray databases
When microarray data are published by journals, most (including MHR) require that the array data be submitted to a publically available database like NCBI's GEO repository. In turn, these repositories ensure that the array data meet the requirements of MIAMEMinimal Information about a Microarray Experiment. The checklist (http://www.mged.org/Workgroups/MIAME/miame.html) includes 
Table II
Significant changes in mean expression levels of genes between functional and regressed (spontaneous and induced) CL from the four selected ontologies presented in Table I a .
Gene the most important information that would allow for replication and independent interpretation of the results: the raw data, final processed data (normalized CEL files), sample information including treatment and dosages, experimental design, array annotation and any laboratory protocols for sample processing. MIAME is an important part of open access of this data, but incomplete entries and the fact that there is no standard format for entry of MIAME data have affected widespread access to some data in public repositories (Brazma, 2009 ). Another limitation is gene annotation of the arrays, as seen in the example of SKAP2 presented above. A recent study, investigating the utility of microarray data in NCBI Pubmed (http://www.ncbi. nlm.nih.gov/pubmed/) searches of gene identifiers, retrieved only 76.6% of existing gene expression data (Piwowar and Chapman, 2010) . This problem applies to use of the rhesus macaque GeneChip, as Affymetrix TM relies on annotation by the NCBI rhesus genome project. Although commercially available since 2005, as of 2008 only 37% of all transcripts were mapped to a UNIQID, and only 52% were annotated to an Entrez Gene ID (Noriega et al., 2009) . This can impact interpretation of results, since much of the important data discovery is derived from pathway analysis of large microarray data sets. In an attempt to improve annotation of the rhesus GeneChip & , resources are available to members of the scientific community as indicated previously (http://www.unmc.edu/rheusgenechip). Full annotation of all rhesus transcripts of this important biomedical species needs to be performed and made available in order for the data of the rhesus gene chip to be fully evaluated. further mining of this resource should lead to novel strategies to improve fertility and contraception.
Summary
During natural luteolysis, it is commonly accepted that the primate CL becomes less sensitive to LH. If this loss in sensitivity to LH is an important event in the demise of the CL, then removal of LH by use of GnRH antagonists should result in similar patterns of gene expression in the CL as spontaneous luteal regression. The GSEA presented here demonstrates that many of the same genes involved in spontaneous luteal regression are affected by GnRH-antagonist induced luteal regression. Changes in expression of several genes (such as LDLR in Table II ) are similar between both Antide and CET treatment and spontaneous regression. The spontaneously regressing CL has more genes in common with Antide than CET-induced luteal regression in this analysis (Table II) . Differences in timing of experiments, as well as duration of treatments and species used, likely contribute to lack of uniformity across GnRH-induced experiments of primate luteolysis (Tables I and II) .The Antide treatment was performed for 3 days in the mid-late luteal phase, closer to the late-luteal phase when spontaneous luteolysis occurs, whereas the CET treatment was more acute (1 day) during the mid-luteal phase when CL function is maximal. Thus, changes noted after 24 h of GnRH antagonist treatment in the CET experiment may represent genes that are more acutely or directly responsive to LH, while the changes noted after 3 days of antagonist treatment (Antide experiment) represent broader genomic changes later in luteolysis. It is well established that PGF2a is the natural uterine luteolysin in ruminants, but prostaglandins of ovarian origin may also promote luetolysis in various species (Wiltbank and Ottobre, 2003) including primates (Sargent et al., 1988) . Bogan et al. (2008a, b) presented evidence that the primate CL switches from production/signaling pathways of luteotropic prostaglandins (PGEs) to luteolytic prostaglandins (PGFs) at the onset of spontaneous luteolysis. Both the Antide and PGF2a experiments demonstrate a down-regulation in prostaglandin E synthase (PTGES) mRNA, analogous to that in natural luteolysis (Table II) . While changes in some genes are similar between PGF2a treatment and spontaneous luteolysis (Tables I and II) , it appears to have more genes in common with 3 day Antide treatment.
Of note, Bishop et al. (2009) also ablated steroid synthesis and replaced progestin (R5020) during the LH ablation (Antide)/replacement experiment, and identified a limited subset of LH-regulated genes whose expression was controlled by progestin (e.g. StAR), or apparently other steroids (e.g. IL1RN). These data are consistent with the hypothesis that local factors, such as prostaglandins or steroids, whose synthesis and/or signaling are influenced by LH, are important agents regulating specific processes leading to luteolysis. These could include mechanisms to limit LH signaling (Zeleznik, 2001) so early time course studies will be needed to evaluate their role(s) in the onset of natural luteolysis.
Comparisons of data sets from microarray experiments are useful in identifying novel or underappreciated gene products or cell signaling pathways in luteolysis. Notably, the largest number of genes presented in Table I , with overlapping expression between natural, GnRH antagonist-and PGF2a-induced luteolysis belong to the ontology of immune system processes. Current understanding of the role of the immune system in luteal regression is expanding, primarily due to studies in non-primate species (Pate et al., 2010) . Investigations of immune-related processes in the primate CL, based on the microarray data, would be valuable and could lead to novel approaches to improve or extend luteal function in certain infertility situations, e.g. recurrent pregnancy loss. However, microarray data will need to be combined with studies of protein levels and signaling activity, as well as classical ablation/replacement studies at the anticipated onset of luteolysis, to unravel the early events of luteolysis. As such, the current and future microarray studies and their analysis of the luteal transcriptome provide an important advance in the search for intraovarian processes controlling luteolysis in primates.
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Supplementary data are available at http://molehr.oxfordjournals. org/.
